eScholarship@UMMS

Title

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging

Authors

Sioban D. Harlow, University of Michigan
Margery Gass, University of Cincinnati College of Medicine
Janet E. Hall, Harvard Medical School
Roger Lobo, Columbia University
Pauline M. Maki, National Institute of Aging
Robert W. Rebar, American Society for Reproductive Medicine
Sherry S. Sherman, National Institutes of Health
Patrick M. Sluss, Harvard Medical School
Tobie J. de Villiers, International Menopause Society
Sybil L. Crawford, University of Massachusetts Medical SchoolFollow

UMMS Affiliation

Department of Preventative and Behavioral Medicine

Publication Date

2012-4

Document Type

Article

Subjects

Aging; Anti-Mullerian Hormone; Biological Markers; Biomedical Research; Cohort Studies; Congresses as Topic; Endocrine System Diseases; Female; Humans; Hypothalamo-Hypophyseal System; Menopause; Ovary; Reproduction; *Women's Health

Disciplines

Physiology

Abstract

OBJECTIVE: The aim of this article is to summarize the recommended updates to the 2001 Stages of Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW + 10 reviewed advances in understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before and after the final menstrual period.

METHODS: Scientists from five countries and multiple disciplines evaluated data from cohort studies of midlife women and in the context of chronic illness and endocrine disorders on change in menstrual, endocrine, and ovarian markers of reproductive aging including antimullerian hormone, inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted by consensus.

RESULTS: STRAW + 10 simplified bleeding criteria for the early and late menopausal transition, recommended modifications to criteria for the late reproductive stage (Stage -3) and the early postmenopause stage (Stage +1), provided information on the duration of the late transition (Stage -1) and early postmenopause (Stage +1), and recommended application regardless of women's age, ethnicity, body size, or lifestyle characteristics.

CONCLUSIONS: STRAW + 10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts. Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making. Nonetheless, important knowledge gaps persist, and seven research priorities are identified.

DOI of Published Version

10.1097/gme.0b013e31824d8f40

Source

Menopause. 2012 Apr;19(4):387-95. Link to article on publisher's site

Journal/Book/Conference Title

Menopause (New York, N.Y.)

Comments

Sybil L. Crawford is a collaborator in the STRAW+10 Collaborative Group.

Related Resources

Link to Article in PubMed

PubMed ID

22343510

Repository Citation

Harlow SD, Gass M, Hall JE, Lobo R, Maki PM, Rebar RW, Sherman SS, Sluss PM, de Villiers TJ, Crawford SL. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Preventive and Behavioral Medicine Publications.
https://doi.org/10.1097/gme.0b013e31824d8f40. Retrieved from https://escholarship.umassmed.edu/prevbeh_pp/239